Navigation Links
MR imaging accurately determines prostate cancer treatment failure
Date:5/19/2008

Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.

The study included 27 patients who had increased levels of prostate specific antigen after being treated with high-intensity focused ultrasonic (HIFU) ablation; 18 of these patients had local tumor progression seen at biopsy. DCE-MRI and DWI had about a 72% accuracy rate in determining which patients needed additional treatment because they had residual or recurrent cancer, said Chan Kyo Kim, MD, lead author of the study. The study found that DWI had fewer false positives than DCE-MRI, but DCE-MRI had fewer false negatives.

After HIFU ablation, the normal anatomy of the prostate gland is completely lost or deformed making it difficult to distinguish benign tissue from cancer, said Dr. Kim. The two imaging studies together, which can be done in about seven minutes, can overcome that challenge, he said.

HIFU is becoming more common as a prostate cancer treatment option, particularly for those persons who cant or dont want to undergo a radical prostatectomy, said Dr. Kim.


'/>"/>

Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
2. High-Tech Imaging No Better for Diagnosing Head/Neck Cancers
3. Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center
4. Improving anxiety treatment through the help of brain imaging: A potential future treatment strategy
5. Imaging Advances Map Brain Areas Affecting Mood
6. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
7. WebReach, Inc. Releases Mirth 1.7.1 - The Linux of Healthcare Now Supports Digital Imaging in Medicine (DiCOM) Standard
8. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
9. Siemens New Clinical Education Training Facility Opens Doors and Expands Offerings for Imaging Professionals
10. VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System
11. Sutter Opens Countys First Non-Hospital-Based Nuclear Imaging Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... (NYLF): Medicine will have the unique opportunity to get hands-on experience in ... high school students an immersive experience to gain invaluable, real-life medical skills that ...
(Date:12/7/2016)... ... 07, 2016 , ... "Today, MHA and mental health advocates ... systems reform legislation in more than fifty years. We applaud the bipartisan action ... elected officials to improving mental health services and supports in our nation. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Kenall Manufacturing, ... new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire that ... amount of light where and when it’s needed. , A 2’ x ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... in their bodies, a researcher at the Icahn School of Medicine at Mount ... The study found that when young children are exposed to secondhand marijuana smoke, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016   IQuity, Inc., ... that Don Hardison has been ... an executive with extensive experience as CEO, ... and Fortune 500 companies within the molecular, clinical ... extensive marketing and sales experience within the pharmaceutical ...
(Date:12/7/2016)... "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by PNS ... in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially available ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... on Lantus expired in 2014. Lantus is the brand name for ...
(Date:12/7/2016)... Dec. 7, 2016 KEY FINDINGS ... benefits such as reducing loss of blood during ... cardiac arrests, rapid recovery after surgeries, and decreasing ... be segmented into convective warming system, surface warming ... turn reduce the stay at hospitals thus, lowering ...
Breaking Medicine Technology: